Chronic kidney disease (CKD) is associated with disturbances in bone strength and metabolism. The alterations of the serotonergic system are also observed in CKD. We used the 5/6 nephrectomy model of CKD to assess the impact of peripheral serotonin and its metabolite- 5-hydroxyindoleacetic acid on bone biomechanical properties and metabolism in growing rats. The animals were sacrificed one and three months after nephrectomy. Biomechanical properties were determined on two different bone types: the cortical bone of the femoral diaphysis using three-point bending test and the mixed cortico-trabecular bone by the bending test of the femoral neck. Biomechanical tests revealed preserved cortical bone strength, whereas work to fracture (W) and yi...
High phosphate intake is known to aggravate renal osteodystrophy along various pathogenetic pathways...
Secondary hyperparathyroidism and abnormalities in tryptophan (TRP) metabolism are commonly observed...
Phosphate burden in chronic kidney disease (CKD) leads to elevated serum fibroblast factor-23 (FGF-2...
Background Disturbances in mineral and bone metabolism represent one of the most complex complicatio...
The diagnosis and treatment of bone disorders in patients with chronic kidney disease (CKD) represen...
Abstract Background Changes in mineral metabolism and bone structure develop early in the course of ...
Introduction. Serotonin receptors are present in osteoblasts and osteoclasts, and serotonin affects ...
Chronic kidney disease (CKD), which leads tocortical bone loss and increasedporosity,increases theri...
INTRODUCTION:Phosphate binding with sevelamer can ameliorate detrimental histomorphometric changes o...
INTRODUCTION: Phosphate binding with sevelamer can ameliorate detrimental histomorphometric changes...
The aim of this thesis is to investigate the changes in the bone tissue of mice that occur as a resu...
There is increasing experimental and clinical evidence that serotonin (5-HT) may regulate bone metab...
Chronic kidney disease (CKD), which leads tocortical bone loss and increasedporosity,increases theri...
U nedavnim istraţivanjima se pokazalo kako periferni serotonin djeluje inhibitorno na proces koštane...
Phosphate burden in chronic kidney disease (CKD) leads to elevated serum fibroblast factor-23 (FGF-2...
High phosphate intake is known to aggravate renal osteodystrophy along various pathogenetic pathways...
Secondary hyperparathyroidism and abnormalities in tryptophan (TRP) metabolism are commonly observed...
Phosphate burden in chronic kidney disease (CKD) leads to elevated serum fibroblast factor-23 (FGF-2...
Background Disturbances in mineral and bone metabolism represent one of the most complex complicatio...
The diagnosis and treatment of bone disorders in patients with chronic kidney disease (CKD) represen...
Abstract Background Changes in mineral metabolism and bone structure develop early in the course of ...
Introduction. Serotonin receptors are present in osteoblasts and osteoclasts, and serotonin affects ...
Chronic kidney disease (CKD), which leads tocortical bone loss and increasedporosity,increases theri...
INTRODUCTION:Phosphate binding with sevelamer can ameliorate detrimental histomorphometric changes o...
INTRODUCTION: Phosphate binding with sevelamer can ameliorate detrimental histomorphometric changes...
The aim of this thesis is to investigate the changes in the bone tissue of mice that occur as a resu...
There is increasing experimental and clinical evidence that serotonin (5-HT) may regulate bone metab...
Chronic kidney disease (CKD), which leads tocortical bone loss and increasedporosity,increases theri...
U nedavnim istraţivanjima se pokazalo kako periferni serotonin djeluje inhibitorno na proces koštane...
Phosphate burden in chronic kidney disease (CKD) leads to elevated serum fibroblast factor-23 (FGF-2...
High phosphate intake is known to aggravate renal osteodystrophy along various pathogenetic pathways...
Secondary hyperparathyroidism and abnormalities in tryptophan (TRP) metabolism are commonly observed...
Phosphate burden in chronic kidney disease (CKD) leads to elevated serum fibroblast factor-23 (FGF-2...